ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials for Unresectable Hepatocellular Carcinoma

Find clinical trials for unresectable hepatocellular carcinoma. Discover research opportunities and treatment options in your area.

29 Active Trials Found

Showing 29 trials on this page

Page 1 of 2

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

NCT ID: NCT06902246

This clinical trial is investigating the effects of a treatment combination called Regorafenib and Yttrium-90 (Y-90) radioembolization for patients with a type of liver cancer known as unresectable...

Not yet recruiting
Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

NCT ID: NCT05667064

This clinical trial is looking at the safety of a combination treatment called IMJUDO and IMFINZI, as well as IMFINZI on its own, for patients with a type of liver cancer known as unresectable hepa...

Recruiting
Type: observational Locations: Chiba, , Japan, Fukuoka, , Japan +45 more

A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

NCT ID: NCT05660213

This clinical trial is studying a new treatment option for patients with unresectable hepatocellular carcinoma, which is a type of liver cancer that cannot be surgically removed. The researchers wa...

Not yet recruiting
Type: observational

Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere

NCT ID: NCT06900543

This clinical trial is looking at a treatment called NRT6003 Injection to see how safe and effective it is for patients with unresectable hepatocellular carcinoma (HCC), which is a type of liver ca...

Recruiting
Phase: PHASE3 Type: interventional Locations: Chengdu, Sichuan, China, Shenyang, Liaoning, China +9 more

Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma

NCT ID: NCT06911255

This clinical trial is studying a combination of three treatments—Tremelimumab, Durvalumab, and Transarterial Chemoembolization (TACE)—to see how safe and effective they are for patients with unres...

Recruiting
Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of

An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery

NCT ID: NCT06117891

This clinical trial is studying how well different treatments work for adults with liver cancer that cannot be surgically removed, known as unresectable hepatocellular carcinoma (uHCC), after they ...

Recruiting
Type: observational Locations: Ann Arbor, Michigan, United States, Multiple Locations, , Korea, Republic Of +31 more

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

NCT ID: NCT03186898

This clinical trial is investigating the effectiveness of two types of radiation therapy—proton therapy and photon therapy—for treating patients with liver cancer that cannot be surgically removed ...

Recruiting
Phase: PHASE3 Type: interventional Locations: Cleveland, Ohio, United States, Saint Louis, Missouri, United States +28 more

SIRT Versus cTACE for Unresectable HCC (CHANCE2506)

NCT ID: NCT06909708

This clinical trial, called CHANCE2506, is studying two different treatments for patients with unresectable hepatocellular carcinoma (HCC), a type of liver cancer that cannot be surgically removed....

Recruiting
Phase: NA Type: interventional Locations: Nanjing, Jiangsu, China

Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma

NCT ID: NCT06896396

This clinical trial is exploring a new treatment approach for patients with advanced liver cancer, known as unresectable hepatocellular carcinoma (HCC), which cannot be surgically removed. The stud...

Not yet recruiting
Phase: PHASE1 Type: interventional Locations: Wuhan, Hubei, China

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

NCT ID: NCT03942328

This clinical trial is looking at a new treatment approach for patients with liver cancer that cannot be removed through surgery. Specifically, the study is testing the safety and effectiveness of ...

Recruiting
Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States

Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer

NCT ID: NCT04605731

This clinical trial is studying the effects of two experimental treatments, durvalumab and tremelimumab, for patients with advanced liver cancer that cannot be surgically removed. These treatments ...

Recruiting
Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma

NCT ID: NCT06788353

This clinical trial is looking at how effective and safe a combination of treatments is for patients with unresectable hepatocellular carcinoma (a type of liver cancer that cannot be surgically rem...

Recruiting
Type: observational Locations: Guangzhou, Guangdong, China

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

NCT ID: NCT05103904

This clinical trial is studying a medication called lenvatinib to see if it can help patients with liver cancer (hepatocellular carcinoma) that has returned after they have received a liver transpl...

Recruiting
Phase: PHASE2 Type: interventional Locations: Birmingham, Alabama, United States, Scottsdale, Arizona, United States +2 more

68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer

NCT ID: NCT05176223

This clinical trial is studying a new imaging technique called 68Ga-PSMA PET to see if it can help doctors better diagnose and manage advanced liver cancer. In this trial, the researchers are focus...

Recruiting
Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States

TACE With Thermosensitive Nanogel Versus Embosphere for HCC

NCT ID: NCT06593964

This clinical trial is looking at a new treatment option for patients with unresectable hepatocellular carcinoma (HCC), which is a type of liver cancer that cannot be removed through surgery. The s...

Recruiting
Phase: NA Type: interventional Locations: Nanjing, , China

Atezolizumab+Bevacizumab+SBRT in Unresectable HCC

NCT ID: NCT05096715

This clinical trial is exploring a new treatment approach for patients with unresectable hepatocellular carcinoma (HCC), a type of liver cancer that cannot be surgically removed. The study is testi...

Recruiting
Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +2 more

Donafenib Combined With Immunotherapy and Local Therapy for Unresectable Hepatocellular Carcinoma That Has Failed in Previous Therapy

NCT ID: NCT06496815

This clinical trial is investigating a medication called donafenib, used alone or in combination with immunotherapy and local treatments, to help patients with unresectable hepatocellular carcinoma...

Not yet recruiting
Phase: PHASE4 Type: interventional

TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma

NCT ID: NCT06485466

This clinical trial is investigating a new treatment approach for patients with unresectable hepatocellular carcinoma (HCC), a type of liver cancer that cannot be surgically removed. The study is l...

Recruiting
Phase: PHASE3 Type: interventional Locations: Chengdu, Sichuan, China

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

NCT ID: NCT05269381

This clinical trial is investigating a new type of personalized vaccine designed to help the immune system recognize and attack advanced solid tumors, which are cancers that have spread beyond thei...

Recruiting
Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC

NCT ID: NCT06360042

This clinical trial is exploring new treatment options for patients with unresectable hepatocellular carcinoma (HCC), which is a type of liver cancer that cannot be surgically removed. The study is...

Recruiting
Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →
Search All Trials Browse All Conditions